/home/venatorx/public_html/dev.venatorx.com/wp-content/themes/venatorx3/header.php on line
43
">
About
Awards
History
Leadership
Board of Directors
Investors and Partners
Pipeline
Cefepime-Taniborbactam
Ceftibuten-Ledaborbactam Etzadroxil
PBP Inhibitor
Publications
Manuscripts
Conference Presentations
News & Events
Press Releases
In the News
Events
Careers
Open Positions
#venatorxcares
Contact
News & Events
Press Releases
In the News
Events
In the News
November 11, 2020
The Guardian
Reasons to be optimistic about new antibiotic development
Two years ago, the outlook for viable antibiotics looked bleak. Now policymakers have realized the scope of the problem, while a number of new innovations are in the pipeline.
November 1, 2020
ACS Publications
The 20 most promising companies still in the antibiotics race
October 26, 2020
Antibiotics: 'The Perfect Storm' Blog
The PASTEUR Act – A View from Industry
October 1, 2020
Life Sciences Pennsylvania (LSPA)
The Newsletter (Q3 2020)
August 14, 2020
The Philadelphia Inquirer
The marketplace for new antibiotics is fundamentally broken | Opinion
April 6, 2020
STAT News
This tiny federal agency was built to respond to a crisis like coronavirus. Now that it’s here, is BARDA ready?
February 19, 2020
Philadelphia Magazine
NextUp: The Company Fighting Hard-to-Treat Bacterial Infections
Archive:
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
You are using a browser that is not supported. Please consider changing your browser
